Elmore Patent Law Group, P.C.
Hepatitis B antiviral agents
The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, thereof: which inhibit the protein(s) encoded by hepatitis B virus (HBV) or interfere with the function of the HBV life cycle of the hepatitis B virus and are also useful as antiviral agents. The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from HBV infection. The invention also relates to methods of treating an HBV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention. 
Enant Pharmaceuticals, Inc.
A A C A
A61P A61K C07D A61K
inventional inventional inventional additional
Yao-Ling Wei Xiaowen Yat Sun Xuri Meizhong Jorden Hui
Qiu Li Peng Or Gao Jin Kass Cao